ArticleNature2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Abstract readRetraction Notice
In one paragraph
Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
51 authors.
Kevin W Ng *Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
Jesse Boumelha *Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.
Katey S S Enfield *Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-4551-6073
Jorge AlmagroAdult Stem Cell Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-0652-6447
Hongui ChaDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Oriol PichCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-1956-1882
Takahiro KarasakiCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-6863-2360
David A MooreCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Roberto SalgadoDepartment of Pathology, ZAS Hospitals, Antwerp, Belgium.ORCID http://orcid.org/0000-0002-1110-3801
Monica SivakumarCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
George YoungRetroviral Immunology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-1203-588X
Miriam Molina-ArcasOncogene Biology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-8176-8948
Sophie de Carné TrécessonOncogene Biology Laboratory, The Francis Crick Institute, London, UK.
Panayiotis AnastasiouOncogene Biology Laboratory, The Francis Crick Institute, London, UK.
Annika FendlerCancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Lewis AuCancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Scott T C ShepherdCancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Carlos Martínez-RuizCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Clare PuttickCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
James R M BlackCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Thomas B K WatkinsCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Hyemin KimDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Seohee ShimDepartment of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Nikhil FaulknerRetroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
Jan AttigRetroviral Immunology Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-2159-2880
Selvaraju VeeriahCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Neil MagnoCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Sophia WardCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-6777-5279
Alexander M FrankellCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-0341-7878
Maise Al BakirCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-0846-8332
Emilia L LimCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Mark S HillCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0718-8934
Gareth A WilsonCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Daniel E CookCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-3347-562X
Nicolai J BirkbakCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-1613-9587
Axel BehrensAdult Stem Cell Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-1557-1143
Nadia YousafRenal and Skin Units, The Royal Marsden Hospital, London, UK.
Sanjay PopatLung Unit, The Royal Marsden Hospital, London, UK.ORCID http://orcid.org/0000-0003-2087-4963
Allan HackshawCancer Research UK and University College London Cancer Trials Centre, London, UK.ORCID http://orcid.org/0000-0002-5570-5070
TRACERx Consortium
CAPTURE Consortium
Crispin T HileyCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Kevin LitchfieldCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0002-3725-0914
Nicholas McGranahanCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.ORCID http://orcid.org/0000-0001-9537-4045
Mariam Jamal-HanjaniCancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
James LarkinRenal and Skin Units, The Royal Marsden Hospital, London, UK.
Se-Hoon LeeDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-9219-3350
Samra TurajlicCancer Dynamics Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-8846-136X
Charles SwantonCancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.ORCID http://orcid.org/0000-0002-4299-3018
Julian DownwardOncogene Biology Laboratory, The Francis Crick Institute, London, UK. julian.downward@crick.ac.uk.ORCID http://orcid.org/0000-0002-2331-4729
George KassiotisRetroviral Immunology Laboratory, The Francis Crick Institute, London, UK. george.kassiotis@crick.ac.uk.ORCID http://orcid.org/0000-0002-8457-2633
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.